If the first trading days of 2021 are the sign of things to come, traders and investors are going to make a lot of money this year. 4 penny stocks on the move to start 2021 are ViaDerma (OTCMKTS: VDRM), Relief Scientific (OTCMKTS: RSCF), Foresight Autonomous Holdings (NASDAQ: FRSX), and AMMO Inc (NASDAQ: POWW).
HOW TO TRADE PENNY STOCKS
First up, it’s important to understand that trading penny stocks are not the same as trading blue chips. As we have stressed repeatedly to our subscribers, the key to trading penny stocks is finding momentum BEFORE it happens and then be patient.
We got our subscribers in early on TSNP, which you can read our latest here, and ENZC, which you can read about here. It’s also best to own a portfolio of quality penny stocks. For some that can be as many as 10 to 20 or more penny stocks.
Now, when we say that we find momentum BEFORE it happens, we are investors looking to position our subscribers BEFORE the move happens. This is where the big money is made and why so many of our subscribers are sitting on gains of over 7750% in ENZC and over 18,650% in TSNP.
We always alert our subscribers first before we publish for our regular readers. This is the value of having a subscription to Insider Financial, which you can sign up for here. We alert our subscribers with our best ideas before our regular readers.
Now we know many prefer to day trade, but we are not day traders here at Insider Financial. It doesn’t suit our personality and we don’t like the intraday moves markets make. We have found we made more money being patient and ignoring the day to day noise of the markets.
If you want to day trade, Insider Financial is not the place for you. When it comes to day trading, and if that’s what you are after, we recommend the folks at True Trading Group, which you can check out their live streams here.
OTC PENNY STOCKS VS NASDAQ PENNY STOCKS
The fact is that there is always a bull market somewhere. That’s why it’s important for penny stock investors to trade both OTC and NASDAQ/NYSE penny stocks. There are always opportunities if you give yourself the flexibility to trade all markets.
Last year, for the first half of 2020, it was much more profitable to trade NASDAQ penny stocks than OTC. That is where we and our subscribers were positioned. We captured the runs in SRNE, NIO, INO, IBIO, WKHS, and many others. Then once the summer came, many of the COVID runners had failed to find momentum. We then pivoted to OTC and caught the runs in TSNP, ENZC, MMEDF, and many others.
So far this year, it’s best to play both OTC and NASDAQ. With Bitcoin running, we are seeing crypto plays making huge moves. With Joe Biden coming into the White House and Democrats taking control of the Senate, we are seeing cannabis and green energy plays catching bids.
In this article, we take a look at 4 penny stocks on the move VDRM, RSCF, FRSX, and POWW to find out what’s behind the move and our outlook for each.
Penny Stock #1 VDRM
VDRM ran almost 1500% after issuing a business update. The run came on the back of an impressive $12.8 million in dollar volume and 11,645 trades as retail investors piled in.
The press release said that some of the highlights of the past 12 months included:
- The FDA approved the registration of a new 55 ml Vitastem spray bottle. This came at the request of hospitals that have tested the product. A larger spray version will be easier to apply the medication to large wounds.
- Liberdol, a new relief pain product was officially launched in 2020. The analgesics market in the U.S. is estimated to be more than $12 billion dollars.
- An extended line of credit was secured for financing future manufacturing. We anticipate sales to top 500,000 units in 2021.
- A large national hospital chain and a major health insurance company have completed successful testing of the Vitastem product. We are now in the final stages of discussions to determine the size of the initial purchase.
- Successful product testing was completed by a major midwestern university with whom we are also in discussions regarding their initial product purchase.
- We have initiated discussions with a major global medical nonprofit that has expressed interest in purchasing Vitastem for use by their doctors and medical staff in treating patients.
Vitastem is available on Amazon for $79 per unit. 500,000 units would be almost $40,000,000 in revenues. With a current market cap of just $23 million, there’s more room for VDRM to run.
Penny Stock #2 RSCF
RSCF started to redeem itself after we told our readers and subscribers to book profits when the stock was trading above $2 a share and which you can read here. We got a lot of negative comments for issuing a SELL recommendation, but those that listened to us saved a lot of money. The reason for the SELL recommendation had nothing to do with us, but rather the PR management had put out at the time.
The good news is that yesterday’s PR redeems management. RSCF received a $416K sales contract for Cryometrix B-90 blast freezers from a prominent pharmaceutical company. This opens the door for more contracts. More contracts means more revenues and that will keep the stock moving higher.
For COVID-19 vaccines, there is an urgent need to keep the vaccines cold. RSCF solves that problem. The Cryometrix B-90 blast freezer is an ultra-cold refrigeration product that can rapidly cool the payload bay from +20C (68F) to -80C (-130F) in 7 minutes. The freezer technology covered under several patents uses a closed liquid nitrogen system keeping the liquid nitrogen from contact with the payload and personnel. The B-90 freezer can be used in the process of creating and storing the newest biopharmaceuticals and mRNA vaccines.
RSCF has a current market cap of $66 million.
Penny Stock #3 FRSX
FRSX is running as it’s a play on autonomous driving. Investors and traders are bidding the stock higher after the company announced that it will begin a pilot project with the intelligent transport system division of a multi-billion-dollar global Japanese vehicle manufacturer to test its Eye-Net™ Protect cellular-based V2X (vehicle-to-everything) accident prevention solution.
Everyone is now speculating which Japanese manufacturer it is. The pilot project will be used to validate and evaluate the software development kit (SDK) configuration of the Eye-Net solution for possible integration into the vehicle manufacturer’s smart city project.
This is Eye-Net Mobile’s third pilot project in Japan, following the Company’s announcements last August about two pilot projects with leading global Japanese technology and electronics companies. Eye-Net Mobile’s market penetration strategy advocates concentrating on one geographic region in order to achieve a critical mass of Eye-Net Protect users in a defined area that could potentially increase the chances of preventing road accidents and saving lives.
Foresight’s vision sensor is a four-camera system based on 3D video analysis, advanced algorithms for image processing, and sensor fusion. Eye-Net Mobile’s cellular-based application is a V2X (vehicle-to-everything) accident prevention solution based on real-time spatial analysis of clients’ movement.
The company’s systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is targeting the Advanced Driver Assistance Systems (ADAS), the semi-autonomous and autonomous vehicle markets and predicts that its systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform, and advanced technology.
FRSX has a current market cap of $425 million.
Penny Stock #4 POWW
POWW is running after the siege of the Capitol and the Georgia elections. Gun stocks run whenever the Democrats are in control as buyers rush to stock up on guns and ammo out of fear that the Democrats are going to take away the Second Amendment right to bear arms. President Obama was always the best salesman for the gun lobby and Joe Biden and Kamala Harris will be no different.
For the fourth-quarter fiscal year 2021, POWW provided revenue guidance of ~$20M (+317% Y/Y, +21% Q/Q), indicating a consecutive quarter of Y/Y triple digit growth. FY21 total revenue guidance increases to ~$58.2M post updated Q4 guidance, an estimated 293% Y/Y increase.
With the company forecast to post $58 million in revenue this year, its current market cap of $456 million makes POWW stock still cheap.
These 4 penny stocks are hot right now. There are always opportunities in penny stocks and it’s our job to find the bull markets. Huge gains can be made in such a short amount of time.
For those that missed out on the recent run in these 4 penny stocks, our best advice is to be patient and throw bids in below the market. Buying dips and selling rips as swing trades remains the best strategy in these markets.
Remember, all it takes is one or two to become a VDRM, RSCF, FRSX, or POWW and you’ve crushed the market indices for the year. Whoever said to avoid penny stocks has no clue what they’re doing.
As always, good luck to all (except the shorts)!
WHEN INSIDER FINANCIAL HAS A STOCK ALERT, IT CAN PAY TO LISTEN. AFTER ALL, OUR FREE NEWSLETTER HAS FOUND MANY TRIPLE-DIGIT WINNERS FOR OUR SUBSCRIBERS. WE SPECIALIZE IN FINDING MOMENTUM BEFORE IT HAPPENS!
Disclosure: We have no position in any of the securities mentioned. We wrote this article ourselves and it expresses our own opinions. We are not receiving compensation for it. We have no business relationship with any company whose stock is mentioned in this article. Insider Financial is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This article is not a solicitation or recommendation to buy, sell, or hold securities. This article is meant for informational and educational purposes only and does not provide investment advice.